跳至主要内容
临床试验/CTRI/2026/03/105339
CTRI/2026/03/105339尚未招募2/3 期

A Study Of Efficacy And Safety Of Microneedle Transdermal Delivery Of Methotrexate 1 Percent Gel Versus Microneedle Transdermal Delivery Of Clobetasol Propionate 0.05 Percent Ointment In The Treatment Of Scalp Alopecia Areata

Dr Rajashekar T S1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年3月14日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1

研究概览

简要总结

This study is to determine the efficacy of Microneedle Transdermal delivery of Methotrexate 1% Gel versus Microneedle Transdermal delivery of Clobetasol Propionate 0.05% Ointment in treatment of Scalp Alopecia Areata. As of now, no study has been done to compare these groups.

Thus making this study a first of its kind.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients of both genders of age more than 18 years with Localised Scalp Alopecia Areata.

排除标准

  • 1.Active systemic infection or localized scalp infection requiring systemic therapy.
  • 2.Severely Immunocompromised.
  • 3.Uncontrolled comorbidities like Diabetes Mellitus 4.Pregnancy.
  • 5.Patients who have undergone treatment with other modalities in past 6 weeks.

研究者

发起方
Dr Rajashekar T S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Rajashekar T S

Sri Devaraj Urs Medical College

研究点 (1)

Loading locations...

相似试验